Brand: ProteoGenix

Idarucizumab Biosimilar – Anti-dabigatran etexilate mesylate mAb – Research Grade

PX-TA1321-100UG
Quality Chart

Clonality:: Monoclonal Antibody
Isotype:: Fab

$238.00

100ug + 238 loyalty points

Size Size

100ug $238.00
1MG $952.00

First Name This field is required. Last Name This field is required. Email This field is required. Company This field is required. Country This field is required. State This field is required.

In Stock
Wide range of unique reagents
Fast worldwide delivery

Idarucizumab Biosimilar - Anti-dabigatran etexilate mesylate mAb - Research Grade

Product name	Idarucizumab Biosimilar - Anti-dabigatran etexilate mesylate mAb - Research Grade
Source	CAS 1362509-93-0
Species	Humanized
Purity	>85%
Buffer	PBS buffer PH7.5
Delivery condition	Blue ice (+4°C)
Delivery Time	3-5 days if in stock; 3-5 weeks if production needed
Storage condition	store at -80°C
Brand	ProteoGenix
Applications	ELISA,WB
Aliases /Synonyms	Idarucizumab,aDabi-Fab,anti-dabigatran,antidote for dabigatran,dabigatran etexilate mesylate,anti-dabigatran etexilate mesylate
Reference	PX-TA1321
Note	For research use only. Not suitable for clinical or therapeutic use.
Isotype	Fab
Clonality	Monoclonal Antibody

Product name	Idarucizumab Biosimilar - Anti-dabigatran etexilate mesylate mAb - Research Grade
Source	CAS 1362509-93-0
Species	Humanized
Purity	>85%
Buffer	PBS buffer PH7.5
Delivery condition	Blue ice (+4°C)
Delivery Time	3-5 days if in stock; 3-5 weeks if production needed
Storage condition	store at -80°C
Brand	ProteoGenix
Applications	ELISA,WB,,,
Aliases /Synonyms	Idarucizumab,aDabi-Fab,anti-dabigatran,antidote for dabigatran,dabigatran etexilate mesylate,anti-dabigatran etexilate mesylate
Reference	PX-TA1321
Note	For research use only. Not suitable for clinical or therapeutic use.
Isotype	Fab
Clonality	Monoclonal Antibody

General information on Anti-dabigatran etexilate mesylate[Drug] (Idarucizumab) Monoclonal Antibody

Idarucizumab is a humanized monoclonal antibody fragment (Fab) derived from an IgG1 isotype antibody that targets and inhibits the oral anticoagulant dabigatran activity, thereby reversing its anticoagulant effect. It has been approved under the trade name Praxbind.

There are no reviews yet.

Be the first to review “Idarucizumab Biosimilar – Anti-dabigatran etexilate mesylate mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Your rating *

In which application did you use the antibody? *

Did it work in your application? * Yes No

Your review *

Name *

Email *

Idarucizumab Biosimilar – Anti-dabigatran etexilate mesylate mAb – Research Grade

Idarucizumab Biosimilar - Anti-dabigatran etexilate mesylate mAb - Research Grade

General information on Anti-dabigatran etexilate mesylate[Drug] (Idarucizumab) Monoclonal Antibody

Recently viewed products

Can’t find what you need?

Cart (0 Items)

Idarucizumab Biosimilar – Anti-dabigatran etexilate mesylate mAb – Research Grade

Specifications Idarucizumab Biosimilar - Anti-dabigatran etexilate mesylate mAb - Research Grade

Description

General information on Anti-dabigatran etexilate mesylate[Drug] (Idarucizumab) Monoclonal Antibody

Documents

Reviews

Recently viewed products

Can’t find what you need?

Cart (0 Items)

Idarucizumab Biosimilar - Anti-dabigatran etexilate mesylate mAb - Research Grade